Alasdair MunroVerified account

@apsmunro

Paediatric Registrar | Clinical Research Fellow Paediatric Infectious diseases | evidence review lead | Husband and dad

United Kingdom
Joined April 2013

Tweets

You blocked @apsmunro

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @apsmunro

  1. Pinned Tweet
    Feb 18

    I have seen some repeated assertions about the evidence on , children and schools recently which sound convincing, but unfortunately are false It is a sensitive and important topic, which is important to get right Shall we bust some myths? 💥 Let's go! 1/10

    Show this thread
    Undo
  2. Where severe symptoms exist for children after acute COVID, it's important we recognise it and support them in their recovery Fortunately, it appears uncommon and comparable to other viral illnesses in children ps: look out for the CLoCK study! 5/5

    Show this thread
    Undo
  3. Finally a study from Australia 🇦🇺 Very low rates of mild symptoms (4% cough and 2% fatigue) at 3-6m follow up 4/5

    Show this thread
    Undo
  4. Next, a study from the UK using ZOE data 🇬🇧 Very low rates of prolonged symptoms at 4 w (4.4%) and <2% beyond 2 months Of note, severity of symptoms was worse in the comparator group who tested negative...! 3/5

    Show this thread
    Undo
  5. First, a large serology screening study from Switzerland 🇨🇭 No difference between seropositive and negative children with symptoms beyond 4 weeks (~10%), and similarly very low rates of symptoms at 6 months (2 & 4%) 2/5

    Show this thread
    Undo
  6. Some decent data is now emerging regarding prolonged symptoms after acute infection in children Fortunately the data looks reassuring 👍 Low prevalence of prolonged symptoms in children, especially when compared to a control group Let's take a look! 1/5

    Show this thread
    Undo
  7. Retweeted

    Latest B.1.617.2 genome counts. Coloured by publish date to show lag. Doesn't look like it was ever growing exponentially nationally. Seems to have flattened in new cases per day. 1/n

    Show this thread
    Undo
  8. Retweeted
    18 hours ago

    My beautiful son, Oscar Sim Munro was born yesterday. ❤️

    Undo
  9. Retweeted
    May 23

    A lot of media attention on B.617 variants & children, schools & outbreaks is some UK regions, but important to keep bigger picture in mind. Schools reopened for 9 million kids 5 weeks ago & infection rates remain flat in school-aged children nationally 👉

    Show this thread
    Undo
  10. Retweeted

    People can only withstand abuse for so long and frankly, this isn’t surprising based off the vitriol we’ve seen. Even worse- when the attacks are from scientists who don’t work in response.

    Undo
  11. Retweeted
    May 23

    Lots of interest in Bolton’s case rates at present, especially case rates in children. Here's a view from Bolton. TLDR: We need to keep community case rates low to protect education. 1/5

    Show this thread
    Undo
  12. May 23

    I feel so lucky and proud to have the amazing people at working around the clock to bring us unprecedented detail, quality, and transparent data and analysis during the pandemic Few people realise we are the envy of the world They are a national treasure like the NHS

    Undo
  13. Retweeted
    May 23

    In absolute awe of the dedication and professionalism involved in working all hours to produce such detailed, comprehensive and transparent reports, to publish them as soon as they are ready, and to be on Twitter at antisocial hours helping to interpret them for a wider audience.

    Undo
  14. Retweeted

    After two doses, the range of protection we’ve been living with is 85-90%. The new data showing 87% for B.1.1.7 implies ~zero drop-off. 81% for B.1.617.2 is a very small dip and the confidence intervals overlap with the 85-90% range, so it’s possible there is no drop-off at all

    Show this thread
    Undo
  15. Retweeted

    SCOOP: Public Health England has presented the first real-world data on vaccine efficacy against B.1.617.2, the variant first found in India. Efficacy against symptomatic B.1.617.2 was 81% after two doses, much higher than many have feared. Story:

    Show this thread
    Undo
  16. May 21

    Another great article about the considerations for vaccinating children against 2 very important points: -We might not need to to contain spread (esp younger kids) -A vaccine given to a child is one not given to another vulnerable adult

    Undo
  17. Retweeted
    May 21

    “Oh, you’re doing a PhD you must be smart!” Me doing a PhD:

    Undo
  18. Retweeted
    May 21

    More evidence that high rates of vaccination in adults reduces cases in unvaccinated kids. Now seen this in Israel and UK. Expect to see this is US, as well.

    Undo
  19. Retweeted
    Replying to

    I don't know why people are running to Twitter or the public with this level of detail. Of all the different things that could go wrong, variants are the most concerning (keep getting good news on vaccines, length of immunity etc.) but uncertainty is huge.

    Undo
  20. May 21
    Undo
  21. May 21

    We’re blown away by the THOUSANDS of people who have registered interest in so far! We are particularly looking for: -Younger adults who had 2 doses of Az/Oxford vaccine -Older adults (>70y) At 18 sites around the UK 🇬🇧 Please share widely!

    Undo

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·